Trade Summary

3 days ago, Polymeropoulos Mihael Hristos, serving as Pres, CEO at Vanda Pharmaceuticals Inc. (VNDA), sold 156,235 shares at $8.17 per share, for a total transaction value of $1,276,971.00. Following this transaction, Polymeropoulos Mihael Hristos now holds 2,704,496 shares of VNDA.

This sale represents a 5.00% decrease in Polymeropoulos Mihael Hristos's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Monday, March 2, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, March 4, 2026, 2 days after the trade was made.

Vanda Pharmaceuticals Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.